Evaluation of the quality of the sentinel lymph node biopsy procedure in patients with breast cancer

Revista española de medicina nuclear
M PajaresE Alonso

Abstract

The Sentinel Lymph Node Biopsy (SLNB) has been demonstrated to be a safe alternative to axillary lymph node dissection in breast cancer staging. The multidisciplinary team must do it with rigor and demonstrate that they have fulfilled some essential criteria. To evaluate the quality of the procedure in the Breast Pathology Unit of Hospital Puerta del Mar, using the self-evaluation guidelines of the Spanish Society of Senology and Breast Pathology. These guidelines establish some objective and measurable evaluation criteria related to the aspects that intervene in the SLNB. Each criterion is associated to 4 levels of quality standards. There are 3 essential criteria of mandatory fulfillment to implement SLNB in the clinical practice. They evaluate care experience (6 criteria), operative aspects (18 criteria, 3 essential) and scientific activity (8 indicators). The initial validation phase included 50 patients and the application phase 120 patients (February 2009). Three essential criteria related to the detection of the sentinel node (98%), accredited sensitivity (90%), and mean number of axillary sentinel nodes (2.1) were fulfilled. The application of self-evaluation guidelines in our Unit obtained a global score of 39 out of 7...Continue Reading

References

Dec 13, 2000·American Journal of Surgery·L TafraM J Edwards
Jun 13, 2001·Journal of the American College of Surgeons·M D McCarterH S Cody
Mar 7, 2003·American Journal of Surgery·Elias E SanidasDimitris D Tsiftsis
Mar 17, 2004·Annals of Surgical Oncology·Dayalan ClarkeUNKNOWN ALMANAC Trialists Group
Jan 27, 2005·The British Journal of Surgery·A GoyalUNKNOWN Axillary Lymphatic Mapping Against Nodal Axillary Clearance (ALMANAC) Trialists Group
Sep 15, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanUNKNOWN American Society of Clinical Oncology
May 26, 2007·Revista española de medicina nuclear·Sergi Vidal Sicart
Oct 19, 2007·European Journal of Nuclear Medicine and Molecular Imaging·John BuscombeUNKNOWN European Association of Nuclear Medicine Oncology Committee and Dosimetry Committee
Feb 24, 2009·Revista española de medicina nuclear·S Vidal-Sicart, M E Rioja Martín
Dec 18, 2009·Revista española de medicina nuclear·J Serrano VicenteA F Conde Martín

❮ Previous
Next ❯

Citations

Jan 21, 2014·Revista española de medicina nuclear e imagen molecular·I Blanco SaizF J Aira Delgado
May 21, 2013·Revista española de medicina nuclear e imagen molecular·A C Rebollo-AguirreS Menjón-Beltrán
Mar 1, 2016·Nuclear Medicine and Biology·Frederick O CopeMichael McGrath

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.